Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0917816 (
mental retardation
)
15,867
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The fragile-X syndrome of
mental retardation
is associated with an expansion in the number of CGG repeats present in the
FMR1
gene. The repeat region is within sequences characteristic of a CpG island. Methylation of CpG dinucleotides that are 5' to the CGG repeat has been shown to occur on the inactive X chromosome of normal females and on the X chromosome of affected fragile-X males, and is correlated with silencing of the
FMR1
gene. The methylation status of CpG sites 3' to the repeat and within the repeat itself has not previously been reported. We have used two methylation-sensitive restriction enzymes, AciI and Fnu4HI, to further characterize the methylation pattern of the
FMR1
CpG island in normal individuals and in those carrying fragile-X mutations. Our results indicate that: (i) CpG dinucleotides on the 3' side of the CGG repeat are part of the CpG island that is methylated during inactivation of a normal X chromosome in females; (ii) the CGG repeats are also part of the CpG island and are extensively methylated as a result of normal X-chromosome inactivation; (iii) similar to normal males, unaffected fragile-X males with small CGG expansions are unmethylated in the CpG island; for affected males, the patterns of methylation are similar to those of a normal, inactive X chromosome; (iv) in contrast to the partial methylation observed for certain sites in lymphocyte DNA, complete methylation was observed in DNA from cell lines containing either a normal inactive X chromosome or a fragile-X chromosome from an affected male.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Methylation analysis of CGG sites in the CpG island of the human FMR1 gene. 130 Nov 65
A model is developed to account for recent molecular observations. It postulates four alleles: normal (N), small rather stable insert (S), larger, unstable insert (Z), and large insert (L). The last-named allele causes the fragile-X phenotype, inactivation of the
FMR1
locus by methylation, and mental impairment; the
FMR1
locus (for fragile-X
mental retardation
locus 1) resides in the FRAXA region. When this model is fit to pre-molecular data, the Z allele appears to be no more frequent than L, while the S allele is polymorphic. Predictions of the model are in reasonable agreement with observation and suggest much more powerful tests of molecular data, including the Laird hypothesis that conversion of Z to L does not occur in active X chromosomes.
...
PMID:Population genetics of the fragile-X syndrome: multiallelic model for the FMR1 locus. 157 Mar 49
The fragile X syndrome is the second leading cause of
mental retardation
after Down syndrome. Fragile X premutations are not associated with any clinical phenotype but are at high risk of expanding to full mutations causing the disease when they are transmitted by a carrier woman. There is no reliable estimate of the prevalence of women who are carriers of fragile X premutations. We have screened 10,624 unselected women by Southern blot for the presence of
FMR1
premutation alleles and have confirmed their size by PCR analysis. We found 41 carriers of alleles with 55-101 CGG repeats, a prevalence of 1/259 women (95% confidence interval 1/373-1/198). Thirty percent of these alleles carry an inferred haplotype that corresponds to the most frequent haplotype found in fragile X males and may indeed constitute premutations associated with a significant risk of expansion on transmission by carrier women. We identified another inferred haplotype that is rare in both normal and fragile X chromosomes but that is present on 13 (57%) of 23 chromosomes carrying
FMR1
alleles with 53-64 CGG repeats. This suggests either (1) that this haplotype may be stable or (2) that the associated premutation-size alleles have not yet reached equilibrium in this population and that the incidence of fragile X syndrome may increase in the future.
...
PMID:Prevalence of carriers of premutation-size alleles of the FMRI gene--and implications for the population genetics of the fragile X syndrome. 748 83
Fragile X Mental Retardation Syndrome is the most common form of hereditary
mental retardation
, and is caused by defects in the
FMR1
gene.
FMR1
is an RNA-binding protein and the syndrome results from lack of expression of
FMR1
or expression of a mutant protein that is impaired in RNA binding. The specific function of
FMR1
is not known. As a step towards understanding the function of
FMR1
we searched for proteins that interact with it in vivo. We have cloned and sequenced a protein that interacts tightly with
FMR1
in vivo and in vitro. This novel protein, FXR2, is very similar to
FMR1
(60% identity). FXR2 encodes a 74 kDa protein which, like
FMR1
, contains two KH domains, has the capacity to bind RNA and is localized to the cytoplasm. The FXR2 gene is located on human chromosome 17 at 17p13.1. In addition,
FMR1
and FXR2 interact tightly with the recently described autosomal homolog FXR1. Each of these three proteins is capable of forming heteromers with the others, and each can also form homomers. FXR1 and FXR2 are thus likely to play important roles in the function of
FMR1
and in the pathogenesis of the Fragile X Mental Retardation Syndrome.
...
PMID:The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. 748 25
Protein H16, which we have identified previously in mammalian cell lines, binds in vitro to two single stranded DNA sites on the late strand of the early promoter of SV40. It has no other single strand binding site in the SV40 genome and does not bind to double stranded DNA. In vitro, H16 can be shown to stimulate strongly the activity of purified RNA polymerase II. Here we have purified this 70 kDa protein from cultured monkey cells and have sequenced three of its tryptic peptides. The analysis indicates that H16 is the simian homolog of human protein K, a nuclear RNA-binding protein found in heterogeneous nuclear ribonucleoprotein (hnRNP) particles, which contains a KH domain present in several proteins including the fragile X
mental retardation
gene product (
FMR1
). The binding affinities of protein K/H16 for RNA and DNA were subsequently compared in detail. They showed that under conditions where K/H16 binds strongly to its single stranded DNA site, it binds very weakly to the corresponding RNA sequence. This result suggests a possible shuttling of the protein from RNA to DNA during processes which involve opening of the DNA double helix.
...
PMID:Identity of the RNA-binding protein K of hnRNP particles with protein H16, a sequence-specific single strand DNA-binding protein. 752 36
The degree to which genetic factors influence human intelligence remains a matter of some controversy. However, there is little doubt that single gene mutations can significantly alter brain development and function. For example, mutations affecting the
FMR1
gene cause the fragile X syndrome, the most prevalent known inherited cause of intellectual dysfunction. The most common mutation occurring in the
FMR1
locus involves expansion of a trinucleotide (CGG)n repeat sequence within the promoter region of the gene. Between 6 and 54 repeats are typically observed in individuals from the general population. When > or = 200 CGG repeats are present, the expanded repeat sequence and an adjacent CpG island are usually hypermethylated, Aa phenomenon associated with transcriptional silencing of the gene and commonly referred to as the
FMR1
full mutation. The intermediate range of repeats (approximately 50 to 200 CGGs), referred to as the premutation, is characterized by the absence of hypermethylation within the promoter region and normal phenotype. Some individuals have a combination of methylated and unmethylated alleles of differing size and are referred to as having mosaic status. Most males with the
FMR1
full mutation function in the mentally retarded range of intelligence; in contrast, females with the
FMR1
full mutation show a broader range of intelligence, from
mental retardation
to normal IQ.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Contribution of the FMR1 gene mutation to human intellectual dysfunction. 758 60
Fragile X syndrome is a leading cause of
mental retardation
worldwide, with an incidence of approximately one case in 2000 live births. It is amongst the most common of human genetic diseases, and was the first to be associated with an unstable trinucleotide (CGG) repeat sequence. It is also characterized by a chromosomal fragile site which was the first of (now) four such sites to be identified at the molecular level. Each shows very similar features suggesting that other representatives of this type of fragile site will likely involve similar sequences. As with the other unstable trinucleotide repeats, the sequence at the fragile X locus is found to be remarkably unstable upon genetic transmission, however many features differ from the other repeats. As repeat expansion at the fragile X locus results in loss of expression of the co-resident
FMR1
gene, the basis for clinical features is best understood in this disorder. Two additional fragile sites in the vicinity have been identified, and at least one of these is associated with
mental retardation
.
...
PMID:The fragile X syndromes. 762 Jan 22
Fragile X syndrome is one of the most common human genetic diseases and the most common cause of hereditary
mental retardation
. The gene that causes fragile X syndrome,
FMR1
, was recently identified and sequenced and found to encode a putative protein of unknown function. Here we report that
FMR1
contains two types of sequence motifs recently found in RNA-binding proteins: an RGG box and two heterogeneous nuclear RNP K homology domains. We also demonstrate that
FMR1
binds RNA in vitro. Using antibodies to
FMR1
, we detect its expression in divergent organisms and in cells of unaffected humans, but fragile X-affected patients express little or no
FMR1
. These findings demonstrate that
FMR1
expression is directly correlated with the fragile X syndrome and suggest that anti-
FMR1
antibodies will be important for diagnosis of fragile X syndrome. Furthermore, the RNA binding activity of
FMR1
opens the way to understanding the function of
FMR1
.
...
PMID:The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. 768 65
Fragile X syndrome is the result of transcriptional suppression of the gene
FMR1
as a result of a trinucleotide repeat expansion mutation. The normal function of the FMR1 protein (FMRP) and the mechanism by which its absence leads to
mental retardation
are unknown. Ribonucleoprotein particle (RNP) domains were identified within FMRP, and RNA was shown to bind in stoichiometric ratios, which suggests that there are two RNA binding sites per FMRP molecule. FMRP was able to bind to its own message with high affinity (dissociation constant = 5.7 nM) and interacted with approximately 4 percent of human fetal brain messages. The absence of the normal interaction of FMRP with a subset of RNA molecules might result in the pleiotropic phenotype associated with fragile X syndrome.
...
PMID:FMR1 protein: conserved RNP family domains and selective RNA binding. 769 1
The fragile X syndrome is the most frequent cause of inherited
mental retardation
. The molecular mechanism of the disorder is based on the expansion of a CGG repeat in the 5' UTR of the
FMR1
gene in the majority of fragile X patients. The instability of this CGG repeat containing region is not restricted to the CGG repeat itself but expands to the flanking region as well. We describe four unrelated fragile X patients that are mosaic for both a full mutation and a small deletion in the CGG repeat containing region. Sequence analysis of the regions surrounding the deletions showed that both the (CGG)n repeat and some flanking sequences were missing in all four patients. The 5' breakpoints of the deletions were found to be located between 75-53 bp proximal to the CGG repeat. This suggests the presence of a hot spot region for deletions in the CGG repeat region of the
FMR1
gene and emphasizes the instability of this region in the presence of an expanded CGG repeat.
...
PMID:Hotspot for deletions in the CGG repeat region of FMR1 in fragile X patients. 771 33
1
2
3
4
5
6
7
8
9
10
Next >>